PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
11.17%
Some net income increase while AVGO is negative at -57.76%. John Neff would see a short-term edge over the struggling competitor.
5.56%
Less D&A growth vs. AVGO's 50.72%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
109.86%
Some yoy growth while AVGO is negative at -256.61%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
2.38%
Less SBC growth vs. AVGO's 46.69%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-104.90%
Negative yoy working capital usage while AVGO is 122.54%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
157.14%
AR growth well above AVGO's 121.79%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-103.28%
Both reduce yoy inventory, with AVGO at -45.65%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-65.08%
Both negative yoy AP, with AVGO at -703.57%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-119.08%
Negative yoy usage while AVGO is 66.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-260.00%
Both negative yoy, with AVGO at -37.78%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
6.41%
Some CFO growth while AVGO is negative at -19.09%. John Neff would note a short-term liquidity lead over the competitor.
71.63%
CapEx growth well above AVGO's 6.60%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
100.00%
Some acquisitions while AVGO is negative at -94087.50%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-36950.00%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-32.00%
We reduce yoy sales while AVGO is 100.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-171750.00%
Both yoy lines negative, with AVGO at -700.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-14695.83%
Both yoy lines negative, with AVGO at -12775.42%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
77.78%
We repay more while AVGO is negative at -15649.57%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
100.00%
Stock issuance far above AVGO's 63.16%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-1771.43%
Both yoy lines negative, with AVGO at -129.16%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.